|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1100 15th Street, NW, Suite 400 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 3071-12
|
||||||||
|
6. House ID# 316200000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Allison C. Wiley, Political Action Coordinator |
Date | 10/20/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 6353 - Ryan Haight Online Pharmacy Consumer Protection Act of 2008
H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008
H. Res. 1437 - Designates October as American Pharmacists Month
Under Line 17: We would like to include Office of the National Coordinator (ONC) for Health Information Technology
H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology (PRO(TECH)T) Act of 2008
H.R. 5491 - Pharmacy Technician Training and Registration Act of 2008
H.R. 4054 - Prevention Through Affordable Access Act
(Docket Number: CMS0009P) HHS Proposed Rule on Health Insurance Reform; Modifications to the Health Insurance Portability and Accountability Act (HIPAA) Electronic Transaction Standards
(Docket Number: CMS-0013-P) HHS Proposed Rule HIPPA Administrative Simplification: Modification to Medical Data Code Set Standards To Adopt ICD-10-CM and ICD-10-PCS
(Docket Number: FDA-2006-N-5015) FDA Proposed Rule on Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling
(Docket Number: DEA-2008-0009) DEA Proposed Rule for Electronic Prescriptions for Controlled Substances
(Docket Number: FDA-2008-N-0466) FDA Over the Counter Cough and Cold Medications for Pediatric Use; Notice of Public Hearing
(Docket Number: FDA-2008-N-0038) FDA Joint Meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Notice of Meeting
(Docket Number: FDA2008D0417) Draft Guidance for the Public and the Food and Drug Administration Staff on Convening Advisory Committee Meetings
(Docket Number: FDA-2005-N-0464) FDA Proposed Rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
(Public Law 110-85) Food and Drug Administration Amendments Act of 2007 Section on Adverse Event Reporting Requirement
(Public Law 100-293) Prescription Drug Marketing Act of 1987 (PDMA)
(Public Law 102-353) Prescription Drug Amendment of 1992 (PDA)
Comments to ONC on Use Case Draft Medication Gaps Document Draft AHIC Extension/Gap
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochain |
|
|
|
Harry |
Hagel |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5348 - American Health Benefits Program (AHBP) Act
H.R. 6680 - The Community and AIDS and Hepatitis Act
H.R. 2994/ S. 3387 - National Pain Care Policy Act of 2007
H.R. 5348 - American Health Benefits Program (AHBP) Act
S. 1693 - Wired for Health Care Quality Act
H.R. 4991 - Vaccine Shortage Preparedness Act of 2008
H.R. 4992 - Medicare Improvement Act of 2007
H.R. 4993 - Vaccines for the Uninsured Adult Act of 2008
S. 2476 - Improved Vaccine Supply Act
H.R. 1108/ S. 625 - The Family Smoking Prevention and Tobacco Control Act
(Docket Number: HHS-OS-2008-0011) HHS Proposed Rule on Ensuring that Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices In Violation of Federal Law
(Docket Number: RIN-0906-AA44) HHS Proposed Rule on Designation of Medically Underserved Populations and
Health Professional Shortage Areas
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochain |
|
|
|
Harry |
Hagel |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6331/ S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275) Sections on Medicaid AMP, Medicare Part D prompt payment, DME Competitive Bidding, Prescription Drug pricing, and e-prescribing
H.Res. 1368 - Relating to the House procedures contained in section 803 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
H.R. 4296/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
H.R. 3700/ S. 1951 - Fair Medicaid Drug Payment Act of 2007
H.R. 3140 - Saving Our Community Pharmacies Act of 2007
H.R. 6252/S. 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008
H.R. 5780 - Medicare Clinical Practitioner Services Coverage Act of 2008
H.R. 5613 - Medicaid Safety Net Act of 2008
H.R. 2408/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
H.R. 971 - Community Pharmacy Fairness Act
S. 1827 - Pharmacist Access and Recognition in Medicare (PhARM) of 2007
S. 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
H.R. 3025 - Medicare Prescription Drug Savings for Our Seniors Act of 2007
S. 1954 Pharmacy Access Improvement Act (PhAIM) of 2007
(Docket Number: CMS-4121-F) CMS Final Rule on Prohibiting Midyear Changes to Medicare Advantage Plans
(Docket Number: CMS 4131-P) CMS Proposed Changes to Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefits Programs
(Docket Number: CMS 4131F) CMS Final Rule on Medicare Program; Medicare Advantage and Prescription Drug Benefit Programs: Final Marketing Provisions
(Docket Number: CMS-1403-P) CMS Amendment on Medicare Program; Revisions to Amendment of the E-Prescribing Exemption for Computer-Generated Facsimiles
(Docket Number: CMS-1405-N) CMS Notice on Medicare Provider Feedback Group Town Hall Meeting
(Docket Number: CMS-7011-N) CMS Notice on Medicare Program: Request for Cosponsors for E-prescribing Educational Conference
(Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement
(Public Law 109-171) Deficit Reduction Act of 2005 Section on Average Manufacturers Price (AMP)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochain |
|
|
|
Harry |
Hagel |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 6122 - Veterans Pain Care Act of 2008
H.R. 6445 - The Veterans Health Care Enhancement Act of 2008 Section on Pain Care Act
S. 2669 - Veterans' Medical Personnel Recruitment and Retention Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochain |
|
|
|
Harry |
Hagel |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
S. 3001 - National Defense Authorization Act of Fiscal Year 2009 Section on TRICARE
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochain |
|
|
|
Harry |
Hagel |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |